Status:
UNKNOWN
Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA)
Lead Sponsor:
Oslo University Hospital
Conditions:
Subclinical Sleep-Activated Epileptiform Activity
CSWS
Eligibility:
All Genders
5-10 years
Phase:
PHASE4
Brief Summary
In clinical practice at the National centre for epilepsy (SSE) in Norway we see many children who have subclinical epileptiform activity in EEG that increases substantially during slow wave sleep (SSE...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Children 5-10 years
- IQ \> 50
Exclusion
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00393614
Start Date
May 1 2007
End Date
March 1 2010
Last Update
September 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet-Radiumhospitalet HF
Oslo, Norway, 0027